1-tert-butyl-4-[1-(4,4-dimethylpentyl)pyrrolidin-3-yl]piperazine;1-tert-butyl-4-[2-[4-[(2-methylpropan-2-yl)oxy]piperidin-1-yl]ethyl]piperazine;2-tert-butyl-7-[3-[(2-methylpropan-2-yl)oxy]propyl]-2,7-diazaspiro[3.5]nonane;1-[3-(5-tert-butyltetrazol-2-yl)propyl]-4-methylpiperazine;1-[1-(4,4-dimethylpentyl)azetidin-3-yl]-4-methylpiperazine;9-methyl-4-[3-[(2-methylpropan-2-yl)oxy]propyl]-1-oxa-4,9-diazaspiro[5.5]undecane;1-[2-[(2-methylpropan-2-yl)oxy]ethyl]-4-[5-[(2-methylpropan-2-yl)oxy]-2-pyridinyl]piperazine;1-[2-[(2-methylpropan-2-yl)oxy]ethyl]-4-[6-[(2-methylpropan-2-yl)oxy]-3-pyridinyl]piperazine;5-[(2-methylpropan-2-yl)oxy]-2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pyrimidine;propane

C165H325N29O10 — CID 158655280

About 1-tert-butyl-4-[1-(4,4-dimethylpentyl)pyrrolidin-3-yl]piperazine;1-tert-butyl-4-[2-[4-[(2-methylpropan-2-yl)oxy]piperidin-1-yl]ethyl]piperazine;2-tert-butyl-7-[3-[(2-methylpropan-2-yl)oxy]propyl]-2,7-diazaspiro[3.5]nonane;1-[3-(5-tert-butyltetrazol-2-yl)propyl]-4-methylpiperazine;1-[1-(4,4-dimethylpentyl)azetidin-3-yl]-4-methylpiperazine;9-methyl-4-[3-[(2-methylpropan-2-yl)oxy]propyl]-1-oxa-4,9-diazaspiro[5.5]undecane;1-[2-[(2-methylpropan-2-yl)oxy]ethyl]-4-[5-[(2-methylpropan-2-yl)oxy]-2-pyridinyl]piperazine;1-[2-[(2-methylpropan-2-yl)oxy]ethyl]-4-[6-[(2-methylpropan-2-yl)oxy]-3-pyridinyl]piperazine;5-[(2-methylpropan-2-yl)oxy]-2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pyrimidine;propane

1-tert-butyl-4-[1-(4,4-dimethylpentyl)pyrrolidin-3-yl]piperazine;1-tert-butyl-4-[2-[4-[(2-methylpropan-2-yl)oxy]piperidin-1-yl]ethyl]piperazine;2-tert-butyl-7-[3-[(2-methylpropan-2-yl)oxy]propyl]-2,7-diazaspiro[3.5]nonane;1-[3-(5-tert-butyltetrazol-2-yl)propyl]-4-methylpiperazine;1-[1-(4,4-dimethylpentyl)azetidin-3-yl]-4-methylpiperazine;9-methyl-4-[3-[(2-methylpropan-2-yl)oxy]propyl]-1-oxa-4,9-diazaspiro[5.5]undecane;1-[2-[(2-methylpropan-2-yl)oxy]ethyl]-4-[5-[(2-methylpropan-2-yl)oxy]-2-pyridinyl]piperazine;1-[2-[(2-methylpropan-2-yl)oxy]ethyl]-4-[6-[(2-methylpropan-2-yl)oxy]-3-pyridinyl]piperazine;5-[(2-methylpropan-2-yl)oxy]-2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pyrimidine;propane (PubChem CID 158655280) has the molecular formula C165H325N29O10 and a molecular weight of 2875.61 g/mol. Its IUPAC name is 1-tert-butyl-4-[1-(4,4-dimethylpentyl)pyrrolidin-3-yl]piperazine;1-tert-butyl-4-[2-[4-[(2-methylpropan-2-yl)oxy]piperidin-1-yl]ethyl]piperazine;2-tert-butyl-7-[3-[(2-methylpropan-2-yl)oxy]propyl]-2,7-diazaspiro[3.5]nonane;1-[3-(5-tert-butyltetrazol-2-yl)propyl]-4-methylpiperazine;1-[1-(4,4-dimethylpentyl)azetidin-3-yl]-4-methylpiperazine;9-methyl-4-[3-[(2-methylpropan-2-yl)oxy]propyl]-1-oxa-4,9-diazaspiro[5.5]undecane;1-[2-[(2-methylpropan-2-yl)oxy]ethyl]-4-[5-[(2-methylpropan-2-yl)oxy]-2-pyridinyl]piperazine;1-[2-[(2-methylpropan-2-yl)oxy]ethyl]-4-[6-[(2-methylpropan-2-yl)oxy]-3-pyridinyl]piperazine;5-[(2-methylpropan-2-yl)oxy]-2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pyrimidine;propane.

Molecular Properties

• Compound Name: 1-tert-butyl-4-[1-(4,4-dimethylpentyl)pyrrolidin-3-yl]piperazine;1-tert-butyl-4-[2-[4-[(2-methylpropan-2-yl)oxy]piperidin-1-yl]ethyl]piperazine;2-tert-butyl-7-[3-[(2-methylpropan-2-yl)oxy]propyl]-2,7-diazaspiro[3.5]nonane;1-[3-(5-tert-butyltetrazol-2-yl)propyl]-4-methylpiperazine;1-[1-(4,4-dimethylpentyl)azetidin-3-yl]-4-methylpiperazine;9-methyl-4-[3-[(2-methylpropan-2-yl)oxy]propyl]-1-oxa-4,9-diazaspiro[5.5]undecane;1-[2-[(2-methylpropan-2-yl)oxy]ethyl]-4-[5-[(2-methylpropan-2-yl)oxy]-2-pyridinyl]piperazine;1-[2-[(2-methylpropan-2-yl)oxy]ethyl]-4-[6-[(2-methylpropan-2-yl)oxy]-3-pyridinyl]piperazine;5-[(2-methylpropan-2-yl)oxy]-2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pyrimidine;propane
• PubChem CID: 158655280
• Molecular Formula: C165H325N29O10
• Molecular Weight: 2875.61 g/mol
• Exact Mass: 2873.58
• IUPAC Name: 1-tert-butyl-4-[1-(4,4-dimethylpentyl)pyrrolidin-3-yl]piperazine;1-tert-butyl-4-[2-[4-[(2-methylpropan-2-yl)oxy]piperidin-1-yl]ethyl]piperazine;2-tert-butyl-7-[3-[(2-methylpropan-2-yl)oxy]propyl]-2,7-diazaspiro[3.5]nonane;1-[3-(5-tert-butyltetrazol-2-yl)propyl]-4-methylpiperazine;1-[1-(4,4-dimethylpentyl)azetidin-3-yl]-4-methylpiperazine;9-methyl-4-[3-[(2-methylpropan-2-yl)oxy]propyl]-1-oxa-4,9-diazaspiro[5.5]undecane;1-[2-[(2-methylpropan-2-yl)oxy]ethyl]-4-[5-[(2-methylpropan-2-yl)oxy]-2-pyridinyl]piperazine;1-[2-[(2-methylpropan-2-yl)oxy]ethyl]-4-[6-[(2-methylpropan-2-yl)oxy]-3-pyridinyl]piperazine;5-[(2-methylpropan-2-yl)oxy]-2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pyrimidine;propane
• SMILES: CC(C)(C)CCCN1CCC(N2CCN(C(C)(C)C)CC2)C1.CC(C)(C)OC1CCN(CCN2CCN(C(C)(C)C)CC2)CC1.CC(C)(C)OCCCN1CCC2(CC1)CN(C(C)(C)C)C2.CC(C)(C)OCCN1CCN(c2ccc(OC(C)(C)C)cn2)CC1.CC(C)(C)OCCN1CCN(c2ccc(OC(C)(C)C)nc2)CC1.CC(C)(C)OCCN1CCN(c2ncc(OC(C)(C)C)cn2)CC1.CCC.CCC.CCC.CN1CCC2(CC1)CN(CCCOC(C)(C)C)CCO2.CN1CCN(C2CN(CCCC(C)(C)C)C2)CC1.CN1CCN(CCCn2nnc(C(C)(C)C)n2)CC1
• InChI: InChI=1S/2C19H33N3O2.C19H39N3O.C19H39N3.C18H32N4O2.C18H36N2O.C16H32N2O2.C15H31N3.C13H26N6.3C3H8/c1-18(2,3)23-14-13-21-9-11-22(12-10-21)17-8-7-16(15-20-17)24-19(4,5)6;1-18(2,3)23-14-13-21-9-11-22(12-10-21)16-7-8-17(20-15-16)24-19(4,5)6;1-18(2,3)22-15-13-21(14-16-22)12-11-20-9-7-17(8-10-20)23-19(4,5)6;1-18(2,3)9-7-10-20-11-8-17(16-20)21-12-14-22(15-13-21)19(4,5)6;1-17(2,3)23-12-11-21-7-9-22(10-8-21)16-19-13-15(14-20-16)24-18(4,5)6;1-16(2,3)20-14-18(15-20)8-11-19(12-9-18)10-7-13-21-17(4,5)6;1-15(2,3)19-12-5-8-18-11-13-20-16(14-18)6-9-17(4)10-7-16;1-15(2,3)6-5-7-17-12-14(13-17)18-10-8-16(4)9-11-18;1-13(2,3)12-14-16-19(15-12)7-5-6-18-10-8-17(4)9-11-18;3*1-3-2/h2*7-8,15H,9-14H2,1-6H3;17H,7-16H2,1-6H3;17H,7-16H2,1-6H3;13-14H,7-12H2,1-6H3;7-15H2,1-6H3;5-14H2,1-4H3;14H,5-13H2,1-4H3;5-11H2,1-4H3;3*3H2,1-2H3
• InChIKey: ICBAXYLSCIUUAJ-UHFFFAOYSA-N
• XLogP: 26.95
• TPSA: 255.50 Ų
• H-Bond Acceptors: 39
• Rotatable Bonds: 39
• Heavy Atoms: 204
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2875.61
LogP ≤ 5	26.95
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	39

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 1-tert-butyl-4-[1-(4,4-dimethylpentyl)pyrrolidin-3-yl]piperazine;1-tert-butyl-4-[2-[4-[(2-methylpropan-2-yl)oxy]piperidin-1-yl]ethyl]piperazine;2-tert-butyl-7-[3-[(2-methylpropan-2-yl)oxy]propyl]-2,7-diazaspiro[3.5]nonane;1-[3-(5-tert-butyltetrazol-2-yl)propyl]-4-methylpiperazine;1-[1-(4,4-dimethylpentyl)azetidin-3-yl]-4-methylpiperazine;9-methyl-4-[3-[(2-methylpropan-2-yl)oxy]propyl]-1-oxa-4,9-diazaspiro[5.5]undecane;1-[2-[(2-methylpropan-2-yl)oxy]ethyl]-4-[5-[(2-methylpropan-2-yl)oxy]-2-pyridinyl]piperazine;1-[2-[(2-methylpropan-2-yl)oxy]ethyl]-4-[6-[(2-methylpropan-2-yl)oxy]-3-pyridinyl]piperazine;5-[(2-methylpropan-2-yl)oxy]-2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pyrimidine;propane?

The IUPAC name of 1-tert-butyl-4-[1-(4,4-dimethylpentyl)pyrrolidin-3-yl]piperazine;1-tert-butyl-4-[2-[4-[(2-methylpropan-2-yl)oxy]piperidin-1-yl]ethyl]piperazine;2-tert-butyl-7-[3-[(2-methylpropan-2-yl)oxy]propyl]-2,7-diazaspiro[3.5]nonane;1-[3-(5-tert-butyltetrazol-2-yl)propyl]-4-methylpiperazine;1-[1-(4,4-dimethylpentyl)azetidin-3-yl]-4-methylpiperazine;9-methyl-4-[3-[(2-methylpropan-2-yl)oxy]propyl]-1-oxa-4,9-diazaspiro[5.5]undecane;1-[2-[(2-methylpropan-2-yl)oxy]ethyl]-4-[5-[(2-methylpropan-2-yl)oxy]-2-pyridinyl]piperazine;1-[2-[(2-methylpropan-2-yl)oxy]ethyl]-4-[6-[(2-methylpropan-2-yl)oxy]-3-pyridinyl]piperazine;5-[(2-methylpropan-2-yl)oxy]-2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pyrimidine;propane (CID 158655280) is 1-tert-butyl-4-[1-(4,4-dimethylpentyl)pyrrolidin-3-yl]piperazine;1-tert-butyl-4-[2-[4-[(2-methylpropan-2-yl)oxy]piperidin-1-yl]ethyl]piperazine;2-tert-butyl-7-[3-[(2-methylpropan-2-yl)oxy]propyl]-2,7-diazaspiro[3.5]nonane;1-[3-(5-tert-butyltetrazol-2-yl)propyl]-4-methylpiperazine;1-[1-(4,4-dimethylpentyl)azetidin-3-yl]-4-methylpiperazine;9-methyl-4-[3-[(2-methylpropan-2-yl)oxy]propyl]-1-oxa-4,9-diazaspiro[5.5]undecane;1-[2-[(2-methylpropan-2-yl)oxy]ethyl]-4-[5-[(2-methylpropan-2-yl)oxy]-2-pyridinyl]piperazine;1-[2-[(2-methylpropan-2-yl)oxy]ethyl]-4-[6-[(2-methylpropan-2-yl)oxy]-3-pyridinyl]piperazine;5-[(2-methylpropan-2-yl)oxy]-2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pyrimidine;propane.

What is the SMILES notation for 1-tert-butyl-4-[1-(4,4-dimethylpentyl)pyrrolidin-3-yl]piperazine;1-tert-butyl-4-[2-[4-[(2-methylpropan-2-yl)oxy]piperidin-1-yl]ethyl]piperazine;2-tert-butyl-7-[3-[(2-methylpropan-2-yl)oxy]propyl]-2,7-diazaspiro[3.5]nonane;1-[3-(5-tert-butyltetrazol-2-yl)propyl]-4-methylpiperazine;1-[1-(4,4-dimethylpentyl)azetidin-3-yl]-4-methylpiperazine;9-methyl-4-[3-[(2-methylpropan-2-yl)oxy]propyl]-1-oxa-4,9-diazaspiro[5.5]undecane;1-[2-[(2-methylpropan-2-yl)oxy]ethyl]-4-[5-[(2-methylpropan-2-yl)oxy]-2-pyridinyl]piperazine;1-[2-[(2-methylpropan-2-yl)oxy]ethyl]-4-[6-[(2-methylpropan-2-yl)oxy]-3-pyridinyl]piperazine;5-[(2-methylpropan-2-yl)oxy]-2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pyrimidine;propane?

The canonical SMILES for 1-tert-butyl-4-[1-(4,4-dimethylpentyl)pyrrolidin-3-yl]piperazine;1-tert-butyl-4-[2-[4-[(2-methylpropan-2-yl)oxy]piperidin-1-yl]ethyl]piperazine;2-tert-butyl-7-[3-[(2-methylpropan-2-yl)oxy]propyl]-2,7-diazaspiro[3.5]nonane;1-[3-(5-tert-butyltetrazol-2-yl)propyl]-4-methylpiperazine;1-[1-(4,4-dimethylpentyl)azetidin-3-yl]-4-methylpiperazine;9-methyl-4-[3-[(2-methylpropan-2-yl)oxy]propyl]-1-oxa-4,9-diazaspiro[5.5]undecane;1-[2-[(2-methylpropan-2-yl)oxy]ethyl]-4-[5-[(2-methylpropan-2-yl)oxy]-2-pyridinyl]piperazine;1-[2-[(2-methylpropan-2-yl)oxy]ethyl]-4-[6-[(2-methylpropan-2-yl)oxy]-3-pyridinyl]piperazine;5-[(2-methylpropan-2-yl)oxy]-2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pyrimidine;propane is CC(C)(C)CCCN1CCC(N2CCN(C(C)(C)C)CC2)C1.CC(C)(C)OC1CCN(CCN2CCN(C(C)(C)C)CC2)CC1.CC(C)(C)OCCCN1CCC2(CC1)CN(C(C)(C)C)C2.CC(C)(C)OCCN1CCN(c2ccc(OC(C)(C)C)cn2)CC1.CC(C)(C)OCCN1CCN(c2ccc(OC(C)(C)C)nc2)CC1.CC(C)(C)OCCN1CCN(c2ncc(OC(C)(C)C)cn2)CC1.CCC.CCC.CCC.CN1CCC2(CC1)CN(CCCOC(C)(C)C)CCO2.CN1CCN(C2CN(CCCC(C)(C)C)C2)CC1.CN1CCN(CCCn2nnc(C(C)(C)C)n2)CC1.

What is the InChIKey of 1-tert-butyl-4-[1-(4,4-dimethylpentyl)pyrrolidin-3-yl]piperazine;1-tert-butyl-4-[2-[4-[(2-methylpropan-2-yl)oxy]piperidin-1-yl]ethyl]piperazine;2-tert-butyl-7-[3-[(2-methylpropan-2-yl)oxy]propyl]-2,7-diazaspiro[3.5]nonane;1-[3-(5-tert-butyltetrazol-2-yl)propyl]-4-methylpiperazine;1-[1-(4,4-dimethylpentyl)azetidin-3-yl]-4-methylpiperazine;9-methyl-4-[3-[(2-methylpropan-2-yl)oxy]propyl]-1-oxa-4,9-diazaspiro[5.5]undecane;1-[2-[(2-methylpropan-2-yl)oxy]ethyl]-4-[5-[(2-methylpropan-2-yl)oxy]-2-pyridinyl]piperazine;1-[2-[(2-methylpropan-2-yl)oxy]ethyl]-4-[6-[(2-methylpropan-2-yl)oxy]-3-pyridinyl]piperazine;5-[(2-methylpropan-2-yl)oxy]-2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pyrimidine;propane?

The InChIKey is ICBAXYLSCIUUAJ-UHFFFAOYSA-N. The full InChI is InChI=1S/2C19H33N3O2.C19H39N3O.C19H39N3.C18H32N4O2.C18H36N2O.C16H32N2O2.C15H31N3.C13H26N6.3C3H8/c1-18(2,3)23-14-13-21-9-11-22(12-10-21)17-8-7-16(15-20-17)24-19(4,5)6;1-18(2,3)23-14-13-21-9-11-22(12-10-21)16-7-8-17(20-15-16)24-19(4,5)6;1-18(2,3)22-15-13-21(14-16-22)12-11-20-9-7-17(8-10-20)23-19(4,5)6;1-18(2,3)9-7-10-20-11-8-17(16-20)21-12-14-22(15-13-21)19(4,5)6;1-17(2,3)23-12-11-21-7-9-22(10-8-21)16-19-13-15(14-20-16)24-18(4,5)6;1-16(2,3)20-14-18(15-20)8-11-19(12-9-18)10-7-13-21-17(4,5)6;1-15(2,3)19-12-5-8-18-11-13-20-16(14-18)6-9-17(4)10-7-16;1-15(2,3)6-5-7-17-12-14(13-17)18-10-8-16(4)9-11-18;1-13(2,3)12-14-16-19(15-12)7-5-6-18-10-8-17(4)9-11-18;3*1-3-2/h2*7-8,15H,9-14H2,1-6H3;17H,7-16H2,1-6H3;17H,7-16H2,1-6H3;13-14H,7-12H2,1-6H3;7-15H2,1-6H3;5-14H2,1-4H3;14H,5-13H2,1-4H3;5-11H2,1-4H3;3*3H2,1-2H3.

What are the key properties of 1-tert-butyl-4-[1-(4,4-dimethylpentyl)pyrrolidin-3-yl]piperazine;1-tert-butyl-4-[2-[4-[(2-methylpropan-2-yl)oxy]piperidin-1-yl]ethyl]piperazine;2-tert-butyl-7-[3-[(2-methylpropan-2-yl)oxy]propyl]-2,7-diazaspiro[3.5]nonane;1-[3-(5-tert-butyltetrazol-2-yl)propyl]-4-methylpiperazine;1-[1-(4,4-dimethylpentyl)azetidin-3-yl]-4-methylpiperazine;9-methyl-4-[3-[(2-methylpropan-2-yl)oxy]propyl]-1-oxa-4,9-diazaspiro[5.5]undecane;1-[2-[(2-methylpropan-2-yl)oxy]ethyl]-4-[5-[(2-methylpropan-2-yl)oxy]-2-pyridinyl]piperazine;1-[2-[(2-methylpropan-2-yl)oxy]ethyl]-4-[6-[(2-methylpropan-2-yl)oxy]-3-pyridinyl]piperazine;5-[(2-methylpropan-2-yl)oxy]-2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pyrimidine;propane?

1-tert-butyl-4-[1-(4,4-dimethylpentyl)pyrrolidin-3-yl]piperazine;1-tert-butyl-4-[2-[4-[(2-methylpropan-2-yl)oxy]piperidin-1-yl]ethyl]piperazine;2-tert-butyl-7-[3-[(2-methylpropan-2-yl)oxy]propyl]-2,7-diazaspiro[3.5]nonane;1-[3-(5-tert-butyltetrazol-2-yl)propyl]-4-methylpiperazine;1-[1-(4,4-dimethylpentyl)azetidin-3-yl]-4-methylpiperazine;9-methyl-4-[3-[(2-methylpropan-2-yl)oxy]propyl]-1-oxa-4,9-diazaspiro[5.5]undecane;1-[2-[(2-methylpropan-2-yl)oxy]ethyl]-4-[5-[(2-methylpropan-2-yl)oxy]-2-pyridinyl]piperazine;1-[2-[(2-methylpropan-2-yl)oxy]ethyl]-4-[6-[(2-methylpropan-2-yl)oxy]-3-pyridinyl]piperazine;5-[(2-methylpropan-2-yl)oxy]-2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pyrimidine;propane has a molecular weight of 2875.61 g/mol, XLogP of 26.95, 39 rotatable bonds, 0 hydrogen bond donors, and 39 hydrogen bond acceptors.

Where does this data come from?

All data for 1-tert-butyl-4-[1-(4,4-dimethylpentyl)pyrrolidin-3-yl]piperazine;1-tert-butyl-4-[2-[4-[(2-methylpropan-2-yl)oxy]piperidin-1-yl]ethyl]piperazine;2-tert-butyl-7-[3-[(2-methylpropan-2-yl)oxy]propyl]-2,7-diazaspiro[3.5]nonane;1-[3-(5-tert-butyltetrazol-2-yl)propyl]-4-methylpiperazine;1-[1-(4,4-dimethylpentyl)azetidin-3-yl]-4-methylpiperazine;9-methyl-4-[3-[(2-methylpropan-2-yl)oxy]propyl]-1-oxa-4,9-diazaspiro[5.5]undecane;1-[2-[(2-methylpropan-2-yl)oxy]ethyl]-4-[5-[(2-methylpropan-2-yl)oxy]-2-pyridinyl]piperazine;1-[2-[(2-methylpropan-2-yl)oxy]ethyl]-4-[6-[(2-methylpropan-2-yl)oxy]-3-pyridinyl]piperazine;5-[(2-methylpropan-2-yl)oxy]-2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pyrimidine;propane is sourced from PubChem (CID 158655280), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).